‘Library’ of de-prioritised pharma compounds available for researchers
UK scientists can apply for MRC funding to use any of the compounds in medical research studies to investigate the underlying mechanics of disease...
List view / Grid view
UK scientists can apply for MRC funding to use any of the compounds in medical research studies to investigate the underlying mechanics of disease...
6 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers sprayed a dye on oesophageal tissue samples taken from people with Barrett’s oesophagus – a condition that risk cancer development...
30 August 2016 | By Niamh Louise Marriott, Digital Content Producer
Used for the first time as part of the team's latest work, the model may become a valuable experimental tool to analyse metastatic potential in sarcomas...
18 August 2016 | By Niamh Louise Marriott, Digital Content Producer
A deep-water marine sponge collected at Fort Lauderdale's coast contains leiodermatolide, a natural product that inhibits the growth of cancer cells as...
16 August 2016 | By Niamh Louise Marriott, Digital Content Producer
The drug development company will collaborate with the research centre on develoing microbiome-derived immunotherapies for cancer patients, to influence the efficacy of checkpoint inhibitors...
10 August 2016 | By Max Planck Institute for Heart and Lung Research
The most common cause of cancer deaths is not the primary tumour itself but metastases that subsequently form. Most tumour cells spread via the bloodstream. To do so, individual tumour cells have to enter blood vessels and leave the bloodstream again at remote locations...
10 August 2016 | By Niamh Louise Marriott, Digital Content Producer
The company 's intends to develop the most effective cannabis strains specific to pain, nausea, epilepsy and PTSD, solving the critical need for real science to support medical marijuana claims...
3 August 2016 | By Plasticell
Plasticell has signed a collaboration agreement with the National University of Ireland, Galway (NUI Galway) focused on methods of eradicating cancer stem cells...
21 July 2016 | By SMi Group
SMi's 5th annual Cancer Vaccines event will showcase 5 key spotlight sessions on the latest advances in vaccine development and cancer therapy breakthroughs when it returns to Central London this autumn...
19 July 2016 | By Niamh Louise Marriott
A*STAR and MSD have formed a two year collaboration aimed at improving cellular delivery of macrocyclic peptides...
Over the past decade significant advances have been made in the fields of genomic and transcriptomic profiling, inspired by the advent of next-generation sequencing (NGS). Yet despite the considerable promise of these new technologies, uptake has been slow. The focus of this review is the use of next-generation transcriptomic analysis…
Tim Hammonds from Cancer Research Technology Discoveries explains how academic HTS laboratories came into being and outlines the challenges facing the new HTS model...